Most revenue
- UNH UnitedHealth Group$447.57B
- MCK McKesson$403.43B
- CVS CVS Health$402.07B
- COR Cencora$321.33B
- CI Cigna$274.90B
Most profit
- JNJ Johnson & Johnson$26.80B
- LLY Eli Lilly$20.64B
- MRK Merck$18.25B
- UNH UnitedHealth Group$12.06B
- GILD Gilead Sciences$8.51B
Highest dividend yield
Rank every health care company →Longest record of raises
- ZTS ZoetisRaised 9+ yrs
- LMAT LeMaitre VascularRaised 9+ yrs
- LLY Eli LillyRaised 9+ yrs
- MCK McKessonRaised 9+ yrs
- UNH UnitedHealth GroupRaised 9+ yrs
Every health care company, by market value
| # | Company | Market value | Price | 1 day | 1 yr | 30 days | Industry |
|---|---|---|---|---|---|---|---|
| 1 | LLY Eli Lilly and Company | $1.36T | $1,443.50 | +1.3% | +42.2% | Pharmaceutical preparations | |
| 2 | JNJ Johnson & Johnson | $687.89B | $285.75 | +0.8% | +49.6% | Pharmaceutical preparations | |
| 3 | ABBV AbbVie Inc | $521.50B | $295.03 | +0.2% | +30.8% | Pharmaceutical preparations | |
| 4 | UNH UnitedHealth Group Incorporated | $365.09B | $407.46 | +0.6% | +25.8% | Hospital and medical service plans | |
| 5 | MRK Merck & Company Inc | $364.26B | $147.76 | +0.6% | +63.7% | Pharmaceutical preparations | |
| 6 | TMO Thermo Fisher Scientific Inc | $259.44B | $700.22 | +0.1% | +21.1% | Measuring and controlling devices | |
| 7 | AMGN Amgen Inc | $251.89B | $465.67 | −0.3% | +42.4% | Biological products | |
| 8 | GILD Gilead Sciences Inc | $208.48B | $168.08 | +0.1% | +37.5% | Biological products | |
| 9 | ABT Abbott Laboratories | $187.95B | $108.52 | +1.2% | −14.0% | Pharmaceutical preparations | |
| 10 | PFE Pfizer Inc | $164.67B | $28.89 | +0.2% | +19.6% | Pharmaceutical preparations | |
| 11 | DHR Danaher Corporation | $163.94B | $233.02 | +0.4% | +6.1% | Industrial instruments for measurement, display, and control | |
| 12 | ISRG Intuitive Surgical Inc | $153.77B | $443.59 | +0.8% | −21.6% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 13 | VRTX Vertex Pharmaceuticals, Inc. | $136.56B | $538.60 | −0.7% | +24.0% | Pharmaceutical preparations | |
| 14 | MDT Medtronic PLC | $131.57B | $102.86 | +1.9% | +10.5% | Electromedical and electrotherapeutic apparatus | |
| 15 | BMY Bristol-Myers Squibb Company | $129.66B | $63.43 | +1.8% | +36.2% | Pharmaceutical preparations | |
| 16 | MCK McKesson Corporation | $127.33B | $1,102.81 | +2.4% | +30.8% | Drugs, proprietaries and druggists' sundries | |
| 17 | SYK Stryker Corporation | $117.88B | $309.64 | −0.9% | −16.1% | Surgical and medical instruments and apparatus | |
| 18 | CVS CVS Health Corp | $114.32B | $89.35 | −0.5% | +16.2% | Drug stores and proprietary stores | |
| 19 | HCA HCA Holdings Inc | $104.25B | $499.05 | −0.3% | +6.2% | General medical and surgical hospitals | |
| 20 | REGN Regeneron Pharmaceuticals Inc | $98.84B | $955.47 | +0.5% | +38.2% | Pharmaceutical preparations | |
| 21 | ELV Elevance Health Inc | $92.84B | $429.69 | −0.1% | +33.5% | Hospital and medical service plans | |
| 22 | MRNA Moderna Inc | $90.38B | $223.37 | −3.5% | +794.9% | Biological products | |
| 23 | CI Cigna Corp | $78.26B | $297.00 | +0.3% | +12.1% | Hospital and medical service plans | |
| 24 | COR Cencora Inc. | $68.51B | $359.03 | +3.0% | −0.7% | Drugs, proprietaries and druggists' sundries | |
| 25 | CAH Cardinal Health Inc | $64.97B | $281.10 | +1.1% | +37.7% | Drugs, proprietaries and druggists' sundries | |
| 26 | BSX Boston Scientific Corp | $64.27B | $44.34 | +0.3% | −57.8% | Surgical and medical instruments and apparatus | |
| 27 | EW Edwards Lifesciences Corp | $61.61B | $107.15 | +1.3% | +24.4% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 28 | BDX Becton Dickinson and Company | $59.39B | $218.03 | +1.1% | +47.2% | Surgical and medical instruments and apparatus | |
| 29 | IDXX IDEXX Laboratories, Inc. | $55.48B | $704.23 | +0.9% | +0.4% | In vitro and in vivo diagnostic substances | |
| 30 | HUM Humana Inc | $54.05B | $450.00 | +1.4% | +92.6% | Hospital and medical service plans | |
| 31 | A Agilent Technologies Inc | $49.04B | $173.96 | +0.6% | +19.3% | Laboratory analytical instruments | |
| 32 | ONC BeiGene, Ltd. | $46.49B | $406.96 | +5.1% | +22.4% | Pharmaceutical preparations | |
| 33 | WAT Waters Corporation | $45.24B | $460.25 | −0.4% | +21.3% | Laboratory analytical instruments | |
| 34 | IQV IQVIA Holdings Inc | $43.69B | $265.12 | −2.2% | +18.6% | Commercial physical and biological research | |
| 35 | GEHC GE HealthCare Technologies Inc. | $37.54B | $83.02 | +1.4% | +12.5% | X-ray apparatus and tubes and related irradiation apparatus | |
| 36 | BIIB Biogen Inc | $37.46B | $253.40 | +1.2% | +53.8% | Biological products | |
| 37 | CNC Centene Corp | $35.28B | $71.27 | +1.4% | +97.5% | Hospital and medical service plans | |
| 38 | MTD Mettler-Toledo International Inc | $34.59B | $1,738.91 | +0.5% | +23.1% | Laboratory analytical instruments | |
| 39 | ZTS Zoetis Inc | $34.06B | $83.82 | +1.0% | −29.3% | Pharmaceutical preparations | |
| 40 | RMD ResMed Inc | $33.69B | $239.53 | +0.3% | −3.9% | Surgical and medical instruments and apparatus | |
| 41 | ILMN Illumina Inc | $32.23B | $213.13 | +2.5% | +76.0% | Laboratory analytical instruments | |
| 42 | DXCM DexCom Inc | $31.08B | $83.33 | +2.4% | +39.5% | Surgical and medical instruments and apparatus | |
| 43 | LH Laboratory Corporation of America Holdings | $30.08B | $370.48 | −0.5% | +39.7% | Medical laboratories | |
| 44 | WST West Pharmaceutical Services Inc | $29.01B | $416.42 | +1.2% | +56.7% | Surgical and medical instruments and apparatus | |
| 45 | DGX Quest Diagnostics Incorporated | $28.56B | $259.60 | −0.0% | +40.7% | Medical laboratories | |
| 46 | ROIV Roivant Sciences Ltd | $28.17B | $38.88 | +6.2% | +89.0% | Pharmaceutical preparations | |
| 47 | STE STERIS plc | $25.67B | $264.32 | +4.3% | +2.6% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 48 | INCY Incyte Corporation | $24.66B | $120.97 | −0.6% | +14.8% | Commercial physical and biological research | |
| 49 | UTHR United Therapeutics Corporation | $23.94B | $562.02 | −0.7% | +23.8% | Pharmaceutical preparations | |
| 50 | VTRS Viatris Inc | $23.87B | $20.82 | +0.7% | +97.5% | Pharmaceutical preparations | |
| 51 | THC Tenet Healthcare Corporation | $22.55B | $283.33 | −1.1% | +38.8% | General medical and surgical hospitals | |
| 52 | ALNY Alnylam Pharmaceuticals Inc | $20.89B | $155.94 | −0.5% | −64.6% | Pharmaceutical preparations | |
| 53 | ZBH Zimmer Biomet Holdings Inc | $19.53B | $103.21 | −1.3% | +15.2% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 54 | MEDP Medpace Holdings Inc | $18.27B | $653.11 | +2.9% | +10.3% | Commercial physical and biological research | |
| 55 | RVTY Revvity Inc. | $17.24B | $154.39 | −1.7% | +65.7% | Laboratory analytical instruments | |
| 56 | EXEL Exelixis Inc | $16.98B | $69.57 | +1.3% | +70.5% | Biological products | |
| 57 | NBIX Neurocrine Biosciences Inc | $16.66B | $164.63 | +3.0% | +6.4% | Biological products | |
| 58 | CRL Charles River Laboratories | $16.19B | $337.97 | −0.8% | +99.7% | Commercial physical and biological research | |
| 59 | SOLV Solventum Corp. | $15.12B | $89.08 | +0.3% | +18.4% | Surgical and medical instruments and apparatus | |
| 60 | JAZZ Jazz Pharmaceuticals PLC | $15.07B | $234.76 | +3.3% | +75.1% | Pharmaceutical preparations | |
| 61 | EHC Encompass Health Corp | $13.50B | $137.54 | −2.6% | +20.4% | Hospitals | |
| 62 | BTSG BrightSpring Health Services, Inc. | $13.36B | $67.15 | +2.0% | +106.0% | Home health care services | |
| 63 | BAX Baxter International Inc | $13.35B | $25.81 | +0.3% | +38.3% | Surgical and medical instruments and apparatus | |
| 64 | GKOS Glaukos Corp | $13.28B | $224.41 | +2.0% | +174.4% | Surgical and medical instruments and apparatus | |
| 65 | ELAN Elanco Animal Health | $12.87B | $25.74 | +8.7% | +19.6% | Pharmaceutical preparations | |
| 66 | PEN Penumbra Inc | $12.58B | $319.21 | −0.6% | +20.6% | Surgical and medical instruments and apparatus | |
| 67 | COO The Cooper Companies, Inc | $11.91B | $62.65 | +0.7% | −12.7% | Ophthalmic goods | |
| 68 | ALGN Align Technology Inc | $11.86B | $168.32 | +0.8% | +20.7% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 69 | HALO Halozyme Therapeutics Inc | $11.81B | $103.63 | −15.7% | +51.5% | Biological products | |
| 70 | TECH Bio-Techne Corp | $11.44B | $72.80 | +0.1% | +20.8% | Biological products | |
| 71 | UHS Universal Health Services Inc | $11.19B | $194.07 | +0.1% | −14.3% | General medical and surgical hospitals | |
| 72 | RGEN Repligen Corporation | $11.09B | $173.49 | +3.0% | +19.7% | Biological products | |
| 73 | DVA DaVita HealthCare Partners Inc | $10.98B | $174.56 | +0.3% | +41.9% | Misc health and allied services | |
| 74 | MOH Molina Healthcare Inc | $10.91B | $208.99 | −3.5% | +42.1% | Hospital and medical service plans | |
| 75 | BMRN Biomarin Pharmaceutical Inc | $10.85B | $56.03 | −0.2% | +8.1% | Pharmaceutical preparations | |
| 76 | PODD Insulet Corporation | $10.58B | $152.48 | +2.1% | −54.2% | Surgical and medical instruments and apparatus | |
| 77 | ENSG The Ensign Group Inc | $10.56B | $181.08 | −0.7% | −0.8% | Skilled nursing care facilities | |
| 78 | AVTR Avantor Inc | $10.48B | $15.47 | +2.2% | +36.7% | Laboratory analytical instruments | |
| 79 | BIO Bio-Rad Laboratories Inc | $10.26B | $381.57 | +3.4% | +24.5% | Laboratory analytical instruments | |
| 80 | GMED Globus Medical | $9.54B | $71.05 | −12.8% | +15.1% | Surgical and medical instruments and apparatus | |
| 81 | HSIC Henry Schein Inc | $9.53B | $86.22 | +0.1% | +17.6% | Medical, dental and hospital equipment and supplies | |
| 82 | BRKR Bruker Corporation | $9.30B | $61.31 | +5.6% | +56.6% | Laboratory analytical instruments | |
| 83 | TGTX TG Therapeutics Inc | $9.04B | $59.83 | +3.2% | +79.9% | Pharmaceutical preparations | |
| 84 | KRYS Krystal Biotech Inc | $8.92B | $300.88 | +0.2% | +50.5% | Biological products | |
| 85 | PTGX Protagonist Therapeutics Inc | $8.62B | $132.04 | −2.4% | +65.5% | Pharmaceutical preparations | |
| 86 | ARWR Arrowhead Pharmaceuticals Inc | $8.22B | $58.16 | +1.2% | +46.9% | Pharmaceutical preparations | |
| 87 | CORT Corcept Therapeutics Incorporated | $7.96B | $72.77 | +1.6% | −0.4% | Pharmaceutical preparations | |
| 88 | ALKS Alkermes Plc | $7.71B | $45.90 | +3.0% | +44.9% | Pharmaceutical preparations | |
| 89 | CYTK Cytokinetics Inc | $7.48B | $53.69 | −3.4% | −11.0% | Pharmaceutical preparations | |
| 90 | AMRX Amneal Pharmaceuticals, Inc. | $7.02B | $20.14 | +3.5% | +72.7% | Pharmaceutical preparations | |
| 91 | CHE Chemed Corp | $6.87B | $528.05 | −1.1% | +23.3% | Home health care services | |
| 92 | LNTH Lantheus Holdings Inc | $6.58B | $100.61 | −0.1% | +87.4% | In vitro and in vivo diagnostic substances | |
| 93 | MSA MSA Safety | $6.55B | $170.14 | +0.1% | +9.6% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 94 | LGND Ligand Pharmaceuticals Incorporated | $6.12B | $306.20 | +2.4% | +47.1% | Pharmaceutical preparations | |
| 95 | HIMS Hims Hers Health Inc | $6.09B | $26.00 | +8.1% | −37.4% | Offices and clinics of doctors of medicine | |
| 96 | RDNT RadNet Inc | $5.99B | $76.00 | −2.6% | −3.7% | Medical laboratories | |
| 97 | TFX Teleflex Incorporated | $5.98B | $150.87 | −0.8% | +40.6% | Surgical and medical instruments and apparatus | |
| 98 | PTCT PTC Therapeutics Inc | $5.47B | $65.44 | −0.3% | −9.8% | Pharmaceutical preparations | |
| 99 | HAE Haemonetics Corporation | $5.46B | $119.93 | −3.4% | +78.7% | Surgical and medical instruments and apparatus | |
| 100 | CON Concentra Group Holdings Parent, Inc. | $5.34B | $42.22 | +0.2% | +127.9% | Specialty outpatient facilities |
The top 100 of 159. The rest of the table needs JavaScript.
‡ Price data for this company stops earlier than the rest; its market value and returns are as of its last price.
Other sectors
Questions investors ask
What is the largest health care company in the US?
Eli Lilly (LLY), worth $1.36T on Nov 6, 2026, followed by Johnson & Johnson ($687.89B) and AbbVie ($521.50B).
How are companies placed in sectors?
By each company’s SEC industry code, mapped onto the sectors investors use today. The codes are decades old, so a few companies, such as Alphabet, Meta, Visa and Mastercard, are placed by hand.
How this ranking is built
- Which companies: the 1514 companies with stock pages: the largest US-listed companies by market value that file annual reports (10-Ks) with the SEC. Foreign companies that file 20-F or 40-F reports instead aren’t covered yet, so ranks are among these companies, not every US-listed stock.
- Sectors: from each company’s SEC industry code, mapped onto the sectors investors use today; a few companies, such as Alphabet, Meta, Visa and Mastercard, are placed by hand. “Industry” is the SEC’s own description.
- Market value: the latest close times the shares outstanding on the cover of the latest 10-K or 10-Q. For a company with several share classes, every class is counted; for depositary shares, the shares each one represents.
- Prices and returns: daily closing prices through Nov 6, 2026. Returns include dividends, reinvested. Financial figures come from each company’s latest 10-K, so fiscal years end on different dates.
- Updates: the rankings are recomputed from the stock pages’ own figures whenever those change, so the two always agree.
For education only, not a recommendation to buy or sell any stock. Past results do not predict future results.